Is Knee Surgery Actually Helping? 10-Year Study Reveals Truth About Partial Meniscectomy
For years, a partial meniscectomy—a procedure where a surgeon trims a damaged piece of the meniscus—has been a go-to treatment for people suffering from knee pain. The prevailing logic was simple: a tear in the meniscus causes the pain, so removing the torn part should fix the problem. However, new long-term evidence suggests this common surgical approach may not only be ineffective but could potentially depart patients worse off.
The findings from the Finnish Degenerative Meniscal Lesion Study (FIDELITY) challenge the biological assumptions that have guided orthopedic surgery for decades. After tracking patients for 10 years, researchers found that trimming a damaged meniscus provides no significant benefit over a placebo procedure.
- No Clinical Benefit: Partial meniscectomy did not improve symptoms or knee function compared to sham surgery.
- Potential Harm: Patients who received the actual surgery reported more knee symptoms and poorer function after a decade.
- Increased Risks: Surgery was linked to a greater progression of osteoarthritis and a higher likelihood of needing further knee operations.
- Aging vs. Injury: Evidence suggests knee pain is often a result of age-related degeneration rather than a specific meniscus tear.
The FIDELITY Study: Setting a New Standard for Evidence
What makes the FIDELITY study particularly powerful is its rigorous design. Rather than simply comparing surgery to “no treatment,” researchers used a sham surgery control group. This means some participants underwent a procedure that looked and felt like surgery but didn’t involve trimming the meniscus, effectively creating a placebo effect.
The study involved 146 participants with degenerative meniscal tears who were randomly assigned to either the partial meniscectomy or the sham procedure. The commitment from the participants was remarkable, with more than 90% completing the full 10-year follow-up phase. This long-term perspective allows doctors to see beyond the immediate post-operative recovery and understand the true trajectory of the joint’s health.
When Surgery Does More Harm Than Good
The long-term data paints a concerning picture for those undergoing the procedure. Patients who actually received the partial meniscectomy did not fare better than the sham group; in many cases, they did worse. After ten years, the surgical group reported:
- Increased knee symptoms.
- Poorer overall knee function.
- More advanced progression of osteoarthritis.
- A higher rate of subsequent knee surgeries.
Teppo Järvinen, Professor at the University of Helsinki and a principal investigator of the study, describes this as a “medical reversal.” This occurs when a therapy that is widely accepted and used across the medical community is eventually proven to be ineffective or even harmful.
“Our findings suggest that this may be an example of what is known as a medical reversal, where broadly used therapy proves ineffective or even harmful.”
— Teppo Järvinen, Professor at the University of Helsinki
Rethinking the Cause of Knee Pain
The disconnect between the surgery’s popularity and its lack of efficacy stems from a fundamental misunderstanding of knee pain. For a long time, surgeons assumed that a medial meniscus tear was the primary driver of pain on the inner side of the knee. The FIDELITY study suggests this “biological credibility” is flawed.
Raine Sihvonen, a Specialist in Orthopaedics and Traumatology and principal investigator of the study, explains that the pain is more likely linked to the general degeneration of the joint brought on by aging, rather than a specific tear that can be “fixed” with a blade. Removing part of the meniscus doesn’t solve the underlying issue of degeneration; it may actually accelerate it.
The Gap Between Evidence and Clinical Practice
If the evidence against partial meniscectomy has been mounting, why is the procedure still so common? Dr. Roope Kalske, a Doctoral Researcher and Specialist in Orthopaedics and Traumatology, notes that randomized studies have already shown a lack of short-term (1-2 years) and medium-term (5 years) benefits. Yet, the procedure remains a routine treatment in many countries.
The struggle to update clinical practice is evident in the conflicting guidelines. While many independent, non-orthopedic organizations have recommended discontinuing the procedure for nearly a decade, major bodies like the American Academy of Orthopedic Surgeons (AAOS) and the British Association for Surgery of the Knee (BASK) have continued to endorse it. This highlights the difficulty the medical community faces when trying to abandon inefficient therapies that have become standard practice.
Frequently Asked Questions
What is a sham surgery?
A sham surgery is a placebo procedure. It mimics the experience of a real operation—including incisions and anesthesia—but does not involve the actual therapeutic intervention (in this case, the trimming of the meniscus). This allows researchers to determine if the improvement is due to the surgery itself or the psychological effect of believing one has been treated.
Does this mean I should never get a meniscectomy?
The FIDELITY study specifically looked at degenerative meniscal tears, which are often related to aging. This is different from acute, traumatic tears (such as those caused by a sudden sports injury), which may have different treatment protocols. Patients should discuss their specific type of tear and long-term goals with their healthcare provider.
What are the alternatives to surgery?
Because the pain is often related to age-related degeneration, focus typically shifts toward conservative management, such as physical therapy, weight management, and other non-surgical interventions aimed at improving joint function and reducing inflammation.
The FIDELITY study, a collaboration between the university hospitals of Helsinki, Kuopio, and Turku, Hatanpää Hospital in Tampere, Hospital Nova in Jyväskylä, and the Finnish Institute for Health and Welfare, serves as a critical reminder that biological assumptions must always be tested against long-term clinical outcomes.